NIH-funded research NIH-funded research

Improving therapies for myotonic dystrophy through coordinated research efforts

Official title: Administrative Core

Funded at University of Florida · NIH-10992313 · Data updated 2026-11-12

This study is all about bringing together researchers and doctors to find better treatments for myotonic dystrophy, a condition that affects how muscles work, so that patients and their families can get the help they need.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startAugust 15, 2024
Project endJuly 31, 2028
Funding year2024
Award (this year)$58,907
NIH project number1P50NS132955-01A1
Project IDNIH-10992313 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are individuals diagnosed with myotonic dystrophy, particularly those who are adults or young adults.

Less likely to help

Patients with other forms of muscular dystrophy or those without a diagnosis of myotonic dystrophy may not benefit from this research.

What this research studies

This research focuses on myotonic dystrophy, a genetic condition that affects muscle function, particularly in adults. The project aims to enhance collaboration among researchers, clinicians, and patient advocacy groups to develop effective treatments for both types of the disease. The Administrative Core will ensure compliance with regulations and facilitate communication among various teams involved in the research. By overseeing the recruitment and enrollment of participants, the project seeks to bridge basic science with clinical applications, ultimately benefiting patients and their families.

Why it matters

Potential benefit: If successful, this research could lead to the development of safe and effective therapies for individuals with myotonic dystrophy.

How similar studies have gone: Previous research efforts in the field of myotonic dystrophy have shown promise in developing therapies, indicating that this approach builds on established successes.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Swanson, Maurice Scott — University of Florida
  • Study coordinator: Swanson, Maurice Scott

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.